Insights

Strategic Partnerships IgNS is actively expanding through partnerships with ACHC and pharmacy networks (e.g., CSI Pharmacy). This indicates a readiness to collaborate on credentialing, standards development, and program expansion, presenting opportunities for joint ventures, training programs, and accreditation services.

Clinical Excellence Demand Recent announcements introduce Distinction in Immunoglobulin Therapy, highlighting a market pull for advanced clinical and operational standards across sites of care. This creates opportunities to offer consulting, compliance coaching, and certification prep services to specialty and infusion pharmacies.

Education and Credentialing IgNS serves a large professional base with standards, education, and credentialing. There is potential to expand paid training modules, credential prep resources, and digital learning programs to healthcare professionals seeking Ig therapy proficiency.

Digital and Outreach Current tech stack includes Drupal, Mailchimp, and WooCommerce, suggesting capacity to scale e-learning, member engagement, and paid credentialing products online. Opportunities exist to optimize marketing automation, online courses, and subscription services.

Market Growth With revenue in the mid seven-figure range and a mission spanning over 35,000 professionals and 8,000 patients, IgNS sits at a growth-ready point to offer enterprise-level accreditation collaborations, sponsorships, and payer-aligned programs to drive broader adoption of Ig therapy practices.

Similar companies to Immunoglobulin National Society (IgNS)

Immunoglobulin National Society (IgNS) Tech Stack

Immunoglobulin National Society (IgNS) uses 8 technology products and services including Drupal, CookieYes, WooCommerce, and more. Explore Immunoglobulin National Society (IgNS)'s tech stack below.

Immunoglobulin National Society (IgNS)'s Email Address Formats

Immunoglobulin National Society (IgNS) uses at least 2 email formats:
Immunoglobulin National Society (IgNS) Email FormatsExamplePercentage
First.Last@ig-ns.orgJohn.Doe@ig-ns.org
90%
First.Middle@ig-ns.orgJohn.Michael@ig-ns.org
10%

Frequently Asked Questions

What is Immunoglobulin National Society (IgNS)'s official website and social media links?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS)'s official website is ig-ns.org and has social profiles on LinkedIn.

How much revenue does Immunoglobulin National Society (IgNS) generate?

Minus sign iconPlus sign icon
As of November 2026, Immunoglobulin National Society (IgNS)'s annual revenue is estimated to be $10M - $25M.

What is Immunoglobulin National Society (IgNS)'s NAICS code?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS)'s NAICS code is 92311 - Administration of Education Programs.

How many employees does Immunoglobulin National Society (IgNS) have currently?

Minus sign iconPlus sign icon
As of November 2026, Immunoglobulin National Society (IgNS) has approximately 9 employees across 2 continents, including North America and South America. Key team members include Owner: M. G., Director Of Educational Resources: R. C. B. and Immunoglobulin National Society: T. S. Explore Immunoglobulin National Society (IgNS)'s employee directory with LeadIQ.

What industry does Immunoglobulin National Society (IgNS) belong to?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS) operates in the Education Administration Programs industry.

What technology does Immunoglobulin National Society (IgNS) use?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS)'s tech stack includes Drupal, CookieYes, WooCommerce, Mailchimp, Microsoft 365, WP Engine, Piwik and Vimeo.

What is Immunoglobulin National Society (IgNS)'s email format?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS)'s email format typically follows the pattern of First.Last@ig-ns.org. Find more Immunoglobulin National Society (IgNS) email formats with LeadIQ.

When was Immunoglobulin National Society (IgNS) founded?

Minus sign iconPlus sign icon
Immunoglobulin National Society (IgNS) was founded in 2011.
Immunoglobulin National Society (IgNS) logo

Immunoglobulin National Society (IgNS)

Education Administration ProgramsCalifornia, United States2-10 Employees

The Immunoglobulin National Society (IgNS) is a national standards-setting organization focused on advancing the practice of immunoglobulin therapy and biologics across diverse clinical specialties. It provides standards of practice, specialized education, credentialing, and a broad set of resources for its members, which include more than 35,000 healthcare professionals and 8,000 patients. The organization operates in the education administration programs space and is based in Calabasas, California.

IgNS serves clinicians and patients who rely on immunoglobulin therapies by offering formal standards and credentialing frameworks, along with access to practice resources to support consistent care. In March 2026, IgNS partnered with the Accreditation Commission for Health Care to launch the Distinction in Immunoglobulin Therapy, a move toward formal recognition in the field. These activities illustrate IgNS's role in coordinating with other organizations to elevate standards in immunoglobulin therapy.

Section iconCompany Overview

Website
ig-ns.org
NAICS Code
92311 - Administration of Education Programs
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $10M - $25M

    Immunoglobulin National Society (IgNS)'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.